Trial intelligence / Profile preview

Pharmacogenetics of CellCept in Renal Transplantation

NCT00337493Phase 4Completed

Sponsor
Roche
Start
Dec 2005
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate mofetil in kidney transplant rejection, sponsored by Roche. Started Dec 2005; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00337493.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00337493.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call